RxDoctor Payments Data

Issam Moussa, MD

Interventional Cardiology · Urbana, ILNPI 1407933302

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Johnson & Johnson at 45.1% of the total. Reporting peaked in 2019 at $20,284 and has fallen 66.1% since, to $6,880 in 2025. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,622in general payments, 2019–2025

Across 274 payments — averaging $319.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$39K
  • Abbott$21K
  • Medtronic$11K
  • Canon Medical Systems USA, Inc.$6K
  • Edwards Lifesciences$3K
  • Boston Scientific$3K
  • plus $5K from 17 others
$267,092in research payments, 2019–2025

Across 26 payments — averaging $10,273 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cathworks, Inc.$203K
  • Heartflow, Inc.$41K
  • Janssen Research & Development, LLC$23K
  • Abbott$400

What the payments were for

  • Consulting fees$15,42518%
  • Speaking & faculty fees$39,86545%
  • Travel & lodging$16,11618%
  • Food & beverage$16,21519%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,622 in reported general payments places this provider in the 90th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$89,274
Medicare patients
143
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$12,430
ClopidogrelClopidogrel Bisulfate75$951
Metoprolol Tartrate50$43
Prednisone12$16

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Urbana

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →